TITLE

EPT'S IMPLANT TRIAL EXCEEDS EXPECTATION

PUB. DATE
April 2004
SOURCE
Worldwide Biotech;Apr2004, Vol. 16 Issue 4, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the efficacy in the implant dose escalation trial by EpiTan Limited in Melbourne, Australia, which commenced in November 2003. Objective of the trial; Expectations of EpiTan on the conclusion of the implant trial; Background of EpiTan.
ACCESSION #
12714967

 

Related Articles

  • A standardized description of graft-containing meshes and recommended steps before the introduction of medical devices for prolapse surgery. Slack, Mark; Ostergard, Donald; Cervigni, Mauro; Deprest, Jan // International Urogynecology Journal;Apr2012, Vol. 23, p15 

    Over the past decade, a huge number of new implants and ancillary devices have been introduced to the market. Most of these have become clinically available with little or no clinical data or research. This is a less-than-ideal situation, and this subgroup of the ad hoc IUGA roundtable...

  • Clinical Effectiveness of Implant-Supported Single-Tooth Replacement: The Toronto Study. Avivi-Arber, Limor; Zarb, George A. // International Journal of Oral & Maxillofacial Implants;1996, Vol. 11 Issue 3, p311 

    Forty-one patients received 49 single-tooth implants placed in different jaw locations. One implant was not osseointegrated at stage 2 surgery. Three successfully osseointegrated implants were not available for follow-up. Forty-five implants were monitored for 1 to 8 years after loading. Each...

  • Medikamente freisetzende Stents im Vergleich zu Bypass-Operationen bei koronarer Herzkrankheit. Gorenoi, Vitali; Dintsios, Charalabos-Markos; Schönermark, Matthias P.; Hagen, Anja // GMS Health Technology Assessment;2009, Vol. 5, p1 

    Background Coronary artery bypass graft (CABG) and percutaneous revascularisations with implantation of drug-eluting stents (DES) are important treatment methods in coronary heart disease (CHD). Research questions The evaluation addresses questions on medical efficacy, health economic parameters...

  • Ethical, Legal and Social Aspects of Brain-Implants Using Nano-Scale Materials and Techniques. Berger, Francois; Gevers, Sjef; Siep, Ludwig; Weltring, Klaus-Michael // NanoEthics;Dec2008, Vol. 2 Issue 3, p241 

    Nanotechnology is an important platform technology which will add new features like improved biocompatibility, smaller size, and more sophisticated electronics to neuro-implants improving their therapeutic potential. Especially in view of possible advantages for patients, research and...

  • TOPICAL TRIAL OF MELANOTAN GETS UK REGULATORY APPROVAL.  // Worldwide Biotech;Mar2005, Vol. 17 Issue 3, p7 

    Reports on the move of the British Medicines and Healthcare products Regulatory Agency to approve a human trial of the drug Melanotan developed by EpiTan Ltd. in March 2005. Details of the clinical trial; Importance of Melanotan in preventing and treating skin diseases associated with...

  • The pursuit of unbiased research: randomized controlled trials. Schulz, Kenneth F. // Contemporary OB/GYN;Feb2000, Vol. 45 Issue 2, p48 

    Focuses on randomized controlled trial in medical research. Discussion on randomization; Benefits of randomization; Nonrandomized comparisons and bias.

  • Determination of the Clinical Importance of Study Results. Man-Son-Hing, Malcolm; Laupacis, Andreas; O'Rourke, Keith; Molnar, Frank J.; Mahon, Jeffery; Chan, Karen B. Y.; Wells, George // JGIM: Journal of General Internal Medicine;Jun2002, Vol. 17 Issue 6, p469 

    Formal statistical methods for analyzing clinical trial data are widely accepted by the medical community. Unfortunately, the interpretation and reporting of trial results from the perspective of clinical importance has not received similar emphasis. This imbalance promotes the historical...

  • Work Practice Guides. Zehrer, Cindy // Applied Clinical Trials;May2001, Vol. 10 Issue 5, p70 

    Focuses on work practice guides in clinical research. Promotion of clinical research best practices; Fostering of consistency within the clinical group.

  • Notes from the field. Hellsten, Donna // Applied Clinical Trials;May2001, Vol. 10 Issue 5, p78 

    Focuses on the use of computers in clinical research. Electronic data capture; Questions to ask prospective vendors.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics